Sinopsys Lacrimal Stent Study for Patients With Chronic Sinusitis or CRS

See also
Status	Clinical Trial	Phase
Terminated	`NCT02972281` - Systematic Search for Primary Immunodeficiency in Adults With Infections	N/A
Recruiting	`NCT03809312` - The Use of Prophylactic Antibiotics in Endoscopy Sinus Surgery for Chronic Rhinosinusitis With or Without Polyp	Phase 4
Withdrawn	`NCT03519061` - Impact of Budesonide Irrigations on Patients With Chronic Rhinosinusitis and Impact on Sinus Surgery Rates	Phase 2/Phase 3
Suspended	`NCT03369717` - Use of Perioperative Antibiotics in Endoscopic Sinus Surgery	Phase 4

See also

Status

Clinical Trial

Phase

Terminated

NCT02972281 - Systematic Search for Primary Immunodeficiency in Adults With Infections

N/A

Recruiting

NCT03809312 - The Use of Prophylactic Antibiotics in Endoscopy Sinus Surgery for Chronic Rhinosinusitis With or Without Polyp

Phase 4

Withdrawn

NCT03519061 - Impact of Budesonide Irrigations on Patients With Chronic Rhinosinusitis and Impact on Sinus Surgery Rates

Phase 2/Phase 3

Suspended

NCT03369717 - Use of Perioperative Antibiotics in Endoscopic Sinus Surgery

Phase 4

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03066908
Study type	Interventional
Source	Sinopsys Surgical
Contact
Status	Suspended
Phase	N/A
Start date	April 20, 2017
Completion date	October 31, 2024

Sinopsys Lacrimal Stent Study for Patients With Chronic Sinusitis or CRS — CRS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms